ArticleCureus2024
Fibromyalgia Concomitant With Rheumatic Diseases in the Eastern Province of Saudi Arabia: A Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesFibromyalgia (FM) is a complex disorder involving pain dysregulation that can occur independently or alongside other rheumatological illnesses, complicating symptom interpretation. Consequently, this study aimed to evaluate the prevalence of secondary FM in patients with rheumatological diseases and its impact using the Revised Fibromyalgia Impact Questionnaire.
methodsThis cross-sectional descriptive study was conducted at the Rheumatology Outpatient Department of King Fahad Military Medical Complex, Dhahran, from August 2023 to October 2023. Patients with primary rheumatological diseases other than FM were recruited. Secondary FM was diagnosed based on the 2016 revisions of the 2010/2011 FM diagnostic criteria. Data on the demographics of patients were collected through self-reported questionnaires.
resultsOverall, 158 women (76%) and 50 men (24%) with a mean age of 45.7 (12.8) years participated in the study. Systemic lupus erythematosus was the primary diagnosis for most patients. Fisher's exact test (p=0.007) indicated a significant but weak association between osteoarthritis and FM. A family history of comorbidity was significantly associated with an FM diagnosis (p<0.043). Having a major life event, such as the death of a kin, was significantly associated with FM (p<0.032). A personal history of functional disorders was significantly linked to a diagnosis of concomitant FM.
conclusionConcomitant FM is frequently undetected in patients with rheumatic diseases. Raising awareness of FM through educational programs may facilitate earlier diagnosis and more effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.